These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 33535206)

  • 41. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alcoholic fatty liver disease elevates estimated coronary heart disease risk to levels comparable with those of nonalcoholic fatty liver disease in the Korean population: a cross-sectional study.
    Kim HJ; Kim JH; Choe WH; Kwon SY; Lee CH
    Clin Mol Hepatol; 2014 Jun; 20(2):154-61. PubMed ID: 25032181
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonalcoholic Fatty Liver Disease Associated With Bladder Cancer.
    Chiang CL; Huang HH; Huang TY; Shih YL; Hsieh TY; Lin HH
    Am J Med Sci; 2020 Aug; 360(2):161-165. PubMed ID: 32448495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period.
    Hamabe A; Uto H; Imamura Y; Kusano K; Mawatari S; Kumagai K; Kure T; Tamai T; Moriuchi A; Sakiyama T; Oketani M; Ido A; Tsubouchi H
    J Gastroenterol; 2011 Jun; 46(6):769-78. PubMed ID: 21302121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN).
    Vusirikala A; Thomas T; Bhala N; Tahrani AA; Thomas GN; Nirantharakumar K
    BMC Endocr Disord; 2020 Jun; 20(1):96. PubMed ID: 32605642
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance.
    Zelber-Sagi S; Ivancovsky-Wajcman D; Fliss Isakov N; Webb M; Orenstein D; Shibolet O; Kariv R
    J Hepatol; 2018 Jun; 68(6):1239-1246. PubMed ID: 29571924
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral health behavior and metabolic syndrome and its components in adults.
    Kobayashi Y; Niu K; Guan L; Momma H; Guo H; Cui Y; Nagatomi R
    J Dent Res; 2012 May; 91(5):479-84. PubMed ID: 22378694
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten-free diet: beyond traditional metabolic factors.
    Tovoli F; Negrini G; Farì R; Guidetti E; Faggiano C; Napoli L; Bolondi L; Granito A
    Aliment Pharmacol Ther; 2018 Sep; 48(5):538-546. PubMed ID: 29984415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-alcoholic fatty liver disease is not associated with a lower health perception.
    Mlynarsky L; Schlesinger D; Lotan R; Webb M; Halpern Z; Santo E; Shibolet O; Zelber-Sagi S
    World J Gastroenterol; 2016 May; 22(17):4362-72. PubMed ID: 27158205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
    Bano A; Chaker L; Plompen EP; Hofman A; Dehghan A; Franco OH; Janssen HL; Darwish Murad S; Peeters RP
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3204-11. PubMed ID: 27270473
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    Sakamoto Y; Oniki K; Kumagae N; Morita K; Otake K; Ogata Y; Saruwatari J
    Dis Markers; 2019; 2019():4065327. PubMed ID: 31929840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.
    Wei J; Lei GH; Fu L; Zeng C; Yang T; Peng SF
    PLoS One; 2016; 11(1):e0147985. PubMed ID: 26824361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.
    Kwak MS; Kim D; Chung GE; Kang SJ; Park MJ; Kim YJ; Yoon JH; Lee HS
    Clin Mol Hepatol; 2012 Dec; 18(4):383-90. PubMed ID: 23323254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population.
    Hung CS; Tseng PH; Tu CH; Chen CC; Liao WC; Lee YC; Chiu HM; Lin HJ; Ho YL; Yang WS; Wu MS; Chen MF
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26199227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between cotinine-verified smoking status and risk of nonalcoholic fatty liver disease.
    Kim NH; Jung YS; Hong HP; Park JH; Kim HJ; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    Liver Int; 2018 Aug; 38(8):1487-1494. PubMed ID: 29359396
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis.
    Ajmera V; Belt P; Wilson LA; Gill RM; Loomba R; Kleiner DE; Neuschwander-Tetri BA; Terrault N;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1511-1520.e5. PubMed ID: 29378307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intermediary effect of inflammation on the association between dietary patterns and non-alcoholic fatty liver disease.
    Xia Y; Zhang Q; Liu L; Meng G; Wu H; Bao X; Gu Y; Sun S; Wang X; Zhou M; Jia Q; Song K; Wu Q; Niu K; Zhao Y
    Nutrition; 2020 Mar; 71():110562. PubMed ID: 31809956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial.
    Kamata Y; Kessoku T; Shimizu T; Kobayashi T; Kurihashi T; Sato S; Kuraji S; Aoyama N; Iwasaki T; Takashiba S; Hamada N; Kodama T; Tamura T; Ino S; Higurashi T; Taguri M; Yamanaka T; Yoneda M; Usuda H; Wada K; Nakajima A; Minabe M
    Trials; 2020 Mar; 21(1):291. PubMed ID: 32293522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.